Shanghai Concord Medical Cancer Center is a medical institution specializing in cancer treatment. Affiliated with Concord Healthcare Management Group under Concord Healthcare Holdings (NYSE: CCM), the center maintains a strategic partnership with MD Anderson Cancer Center in the United States, dedicated to delivering internationally recognized cancer diagnosis and treatment services. The center has adopted internationally advanced treatment guidelines, medical procedures, and management models. Equipped with world-leading cancer diagnostic and therapeutic devices, it employs a multidisciplinary integrated treatment approach and comprehensive disease management model to deliver high-end, integrated cancer care encompassing prevention, diagnosis, treatment, and rehabilitation.
The outpatient department features multiple specialized divisions including Oncology, Radiation Oncology, Breast Cancer, Gastric Cancer, Liver Cancer, Colorectal Cancer, Lung Cancer, Medical Imaging, and Radiology, delivering comprehensive multidisciplinary care. The outpatient department is equipped with advanced medical devices such as GE low-dose spiral CT, GE Signa HD MRI, GE LOGIQ E9 color ultrasound, and GE Senorgraphe DS Stereotaxy mammography, providing patients with comprehensive medical imaging services. Additionally, the outpatient department delivers precision radiotherapy services. Guided by MD Anderson Cancer Center's radiotherapy protocols, it strictly adheres to standardized medical procedures and quality control systems to ensure treatment efficacy.
Address: Building 4, No. 170 Danshui Road, Huangpu District
Hours: Weekdays, 8:30 am - 5 pm; Saturday, 8:30 am - 12 pm
Service Languages: English, Japanese
Featured Diagnosis and Treatment Projects:
Cancer Radiotherapy, Chemotherapy, Traditional Chinese Medicine Treatment, Diagnostic Imaging (CT and MR)
Contact: 021-3331-9991